Flaxseed oil
Flaxseed oil is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Omega-3 Fatty Acids on Markers of Inflammation
Alpha-linolenic Acid and Blood Pressure
Study of the Safety and Efficacy of Dietary Buglossoides Oil
Edible Oils in the Treatment of Constipation of Hemodialysis Patients
Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Gestational Diabetic Patients
Clinical Trials (8)
Effects of Omega-3 Fatty Acids on Markers of Inflammation
Alpha-linolenic Acid and Blood Pressure
Study of the Safety and Efficacy of Dietary Buglossoides Oil
Edible Oils in the Treatment of Constipation of Hemodialysis Patients
Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Gestational Diabetic Patients
Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans
Supplementation With Flaxseed Oil in the State of Rio de Janeiro
Study on the Possible Effects of Diet Supplementation With Essential Fatty Acids in Chocolate Craving Volunteers
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8